Ailanthus Altissima-derived Ailanthone enhances Gastric Cancer Cell Apoptosis by Inducing the Repression of Base Excision Repair by Downregulating p23 Expression
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 17 (11) , 2811-2825
Abstract
Chemotherapy plays an irreplaceable role in the treatment of GC, but currently available chemotherapeutic drugs are not ideal. The application of medicinal plants is an important direction for new drug discovery. Through drug screening of GC organoids, we determined that ailanthone has an anticancer effect on GC cells in vitro and in vivo. We also found that AIL can induce DNA damage and apoptosis in GC cells. Further transcriptome sequencing of PDX tissue indicated that AIL inhibited the expression of XRCC1, which plays an important role in DNA damage repair, and the results were also confirmed by western blotting. In addition, we found that AIL inhibited the expression of P23 and that inhibition of P23 decreased the expression of XRCC1, indicating that AIL can regulate XRCC1 via P23. The results of coimmunoprecipitation showed that AIL can inhibit the binding of P23 and XRCC1 to HSP90. These findings indicate that AIL can induce DNA damage and apoptosis in GC cells. Meanwhile, AIL can decrease XRCC1 activity by downregulating P23 expression to inhibit DNA damage repair. The present study sheds light on the potential application of new drugs isolated from natural medicinal plants for GC therapy.Keywords
This publication has 49 references indexed in Scilit:
- Heat shock protein 90α (HSP90α), a substrate and chaperone of DNA-PK necessary for the apoptotic responseProceedings of the National Academy of Sciences, 2012
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- Global Functional Map of the p23 Molecular Chaperone Reveals an Extensive Cellular NetworkMolecular Cell, 2011
- High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug ResistanceCancer Research, 2010
- Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44Stem Cells, 2009
- Single-strand break repair and genetic diseaseNature Reviews Genetics, 2008
- HSP90: The Rosetta stone for cellular protein dynamics?Cell Cycle, 2008
- Base excision repair processing of abasic site/single-strand break lesions within clustered damage sites associated with XRCC1 deficiencyNucleic Acids Research, 2007
- Tumor Selectivity of Hsp90 Inhibitors: The Explanation Remains ElusiveACS Chemical Biology, 2006
- Hsp90–Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosisOncogene, 2005